Y. Hayashi, “Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis”, J Hematol, vol. 14, no. 2, pp. 66–73, Apr. 2025, doi: 10.14740/jh2010.